EFTA00402252.pdf

From: Lesley Groff <lesley.jee®gmail.com> To: "Spongberg, Don" Subject: Re: Metavana Date: Mon, 05 Nov 2012 21:17:58 +0000 Don...Jeffrey says he can speak with you but he is not in NY until Nov. 16th or 20th.. On Nov 5, 2012, at 3:47 PM, Spongberg, Don wrote: Dear Lesley, Thank you for your time as I described Metavana and the connection with Dr. Murray Gell-Mann. He is an advisor to Metavana and has worked for decades with Dr. Minh Duong-van, Metavana's Chief Scientific Officer. The two have especially worked together applying chaos theory to linguistics. I have attached a summary and have emailed a copy of all the offering documents. I can send you a hard copy if you give me a mailing address. Dr. Minh Duong-van will be in New York City for meetings on November 8 and 9th. He will be accompanied by Michael Tupanjanin, CEO. They would welcome meeting with or speaking to Mr. Epstein if he is available. In addition to the work Metavana has done with Satmetrix and Salesforce on the "Spark Score" and sentiment analysis, Dr. Minh has worked on correlating twitter sentiment with stock prices and election outcomes. I hope Mr. Epstein finds this information interesting and would like to discuss this further. Regards, Donald R. Spongberg Senior Managing Director Spencer Trask Ventures, Inc. 1700 E. Putnam Ave, Old Greenwich, CT 06870 Direct: Fax: This email message is for the sole use of the intended recipient and may contain confidential and privileged information. My unauthorized review. use. disclosure or distribution is prohibited. If you are not the intended recipient. please contact the sender by reply email and destroy all copies of the original message. Any views expressed in this message are those of the individual sender, except where the sender specifically slates them to be the views of . This is neither an offer nor a solicitation of an offer to buy or sell securities. This email message is for the sole use of the intended recipient and may contain confidential and privileged tifamation. Any unauthorized review. use. disclosure or distribution is prohibited. If you are not the intended recipient. please contact the sender by reply email and destroy all copies of the original message. Any views expressed in this message are those of the individual sender. except where the sender specifically states them to be the views of Spencer Trask Ventures. This is neither an offer nor a solicitation of an offer to buy or sell securities. EFTA00402252 <Metavana executive overview FINAL Jun18 2012.pdf> EFTA00402253